bioAffinity Technologies (BIAF) Earnings Date & Reports
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BIAF is expected to report earnings to fall 37.31% to -10 cents per share on August 19
Q2'25
Est.
$-0.10
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
The last earnings report on May 15 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 1.21M shares outstanding, the current market capitalization sits at 23.27M.